Gamco, Gabelli up ownership of Biosite to 11.87%

By Lisa Kerner

Charlotte, N.C., June 11 - Biosite Inc. shareholders led by Gamco Asset Management Inc. and Gabelli Funds, LLC continued to increase their stake in the company with the purchase of 21,619 shares of the company's stock between June 1 and June 8, priced from $91.97 to $92.09.

The investors beneficially own 2,028,879 shares, or 11.87%, of the San Diego-based biomedical company's outstanding stock, according to a schedule 13D filed with the Securities and Exchange Commission.

On June 5, the investors reported a 10.86% stake in Biosite, an increase from the 9.8% reported on May 23.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.